Context Therapeutics amended charter to authorize 310 million shares
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day